Health Ministry further limits use of codeine

Israel adopting stricter limitations in light of recommendation by European Medicines Agency.

By
July 13, 2015 16:18
Cough syrup

Cough syrup [Illustrative]. (photo credit: WIKIMEDIA COMMONS/STICKPEN)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Although the Health Ministry has warned before about the use of cough syrup or other medications containing the opioid codeine for children, it has now adopted stricter limitations after the European Medicines Agency made new recommendations.

The EMA recommended that codeine not be used for children under the age of 12; that lactating women not take it; that it not be given to children between 12 and 18 who have respiratory difficulties and underwent surgery for the removal of their tonsils or adenoids (or any other children of these ages who have breathing difficulties); and that it not be used by patients who, when they took codeine, it underwent ultra-rapid CYP2D6 metabolizers and turns into morphine.

Be the first to know - Join our Facebook page.


In most patients, there is no knowledge about the ability to break codeine down into morphine, so doctors should look for signs of toxicity including dizziness, breathing difficulties, sleepiness and confusion. If there are such side effects, go quickly for medical help.

The ministry in Jerusalem thus decided to adopt the EMA recommendations. It listed codeine products made by Rekah Pharmaceutical Industries, Sam-On, Teva, Vitamed Ltd., CTS Chemical Industries, Reckitt Benckiser, Taro and Trima Israel.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Giant Relic of Disrupted “Tadpole” Galaxy.
November 19, 2018
Israeli astronomers discover 'tadpole'-shaped galaxy

By YVETTE J. DEANE